265 related articles for article (PubMed ID: 35468192)
1. Tumor-induced Osteomalacia: A Systematic Review and Individual Patient's Data Analysis.
Rendina D; Abate V; Cacace G; D'Elia L; De Filippo G; Del Vecchio S; Galletti F; Cuocolo A; Strazzullo P
J Clin Endocrinol Metab; 2022 Jul; 107(8):e3428-e3436. PubMed ID: 35468192
[TBL] [Abstract][Full Text] [Related]
2. Clinical Characteristics of Malignant Phosphaturic Mesenchymal Tumor Causing Tumor-Induced Osteomalacia.
Abate V; Vergatti A; De Filippo G; Damiano V; Menale C; D'Elia L; Rendina D
J Clin Endocrinol Metab; 2024 Feb; 109(3):e1006-e1011. PubMed ID: 38006315
[TBL] [Abstract][Full Text] [Related]
3. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
[TBL] [Abstract][Full Text] [Related]
4. Clinical Challenges in Diagnosis, Tumor Localization and Treatment of Tumor-Induced Osteomalacia: Outcome of a Retrospective Surveillance.
Hidaka N; Koga M; Kimura S; Hoshino Y; Kato H; Kinoshita Y; Makita N; Nangaku M; Horiguchi K; Furukawa Y; Ohnaka K; Inagaki K; Nakagawa A; Suzuki A; Takeuchi Y; Fukumoto S; Nakatani F; Ito N
J Bone Miner Res; 2022 Aug; 37(8):1479-1488. PubMed ID: 35690913
[TBL] [Abstract][Full Text] [Related]
5. Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.
Hu FK; Yuan F; Jiang CY; Lv DW; Mao BB; Zhang Q; Yuan ZQ; Wang Y
Chin J Cancer; 2011 Nov; 30(11):794-804. PubMed ID: 22035861
[TBL] [Abstract][Full Text] [Related]
6. Ameloblastic Fibroodontoma of Mandible Causing Tumor Induced Osteomalacia: A Case Report with Review of 88 Phosphaturic Oral Neoplasms.
Mishra D; Kaur H; Bhalla AS; Manchanda S; Sasikumar J; Agarwal B; Roychoudhury A
Head Neck Pathol; 2021 Sep; 15(3):975-988. PubMed ID: 33394371
[TBL] [Abstract][Full Text] [Related]
7. Long-term use of burosumab for the treatment of tumor-induced osteomalacia.
Crotti C; Zucchi F; Alfieri C; Caporali R; Varenna M
Osteoporos Int; 2023 Jan; 34(1):201-206. PubMed ID: 35925260
[TBL] [Abstract][Full Text] [Related]
8. Tumor-induced Osteomalacia: A Comprehensive Review.
Minisola S; Fukumoto S; Xia W; Corsi A; Colangelo L; Scillitani A; Pepe J; Cipriani C; Thakker RV
Endocr Rev; 2023 Mar; 44(2):323-353. PubMed ID: 36327295
[TBL] [Abstract][Full Text] [Related]
9. Tumor-induced osteomalacia: experience from a South American academic center.
González G; Baudrand R; Sepúlveda MF; Vucetich N; Guarda FJ; Villanueva P; Contreras O; Villa A; Salech F; Toro L; Michea L; Florenzano P
Osteoporos Int; 2017 Jul; 28(7):2187-2193. PubMed ID: 28341900
[TBL] [Abstract][Full Text] [Related]
10. Surgical treatment of recurrent spinal phosphaturic mesenchymal tumor-induced osteomalacia: A case report.
Liu S; Zhou X; Song A; Huo Z; Wang Y; Liu Y
Medicine (Baltimore); 2020 Jan; 99(4):e18603. PubMed ID: 31977851
[TBL] [Abstract][Full Text] [Related]
11. Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation.
Horng JC; Van Eperen E; Tutton S; Singh R; Shaker JL; Wooldridge AN
Osteoporos Int; 2021 Sep; 32(9):1895-1898. PubMed ID: 33655402
[TBL] [Abstract][Full Text] [Related]
12. Challenges in the management of tumor-induced osteomalacia (TIO).
Brandi ML; Clunie GPR; Houillier P; Jan de Beur SM; Minisola S; Oheim R; Seefried L
Bone; 2021 Nov; 152():116064. PubMed ID: 34147708
[TBL] [Abstract][Full Text] [Related]
13. Tumor-Induced Osteomalacia.
Florenzano P; Hartley IR; Jimenez M; Roszko K; Gafni RI; Collins MT
Calcif Tissue Int; 2021 Jan; 108(1):128-142. PubMed ID: 32504138
[TBL] [Abstract][Full Text] [Related]
14. Tumor-induced osteomalacia: An overview.
Jadhav SS; Shah R; Patil V
Best Pract Res Clin Endocrinol Metab; 2024 Mar; 38(2):101834. PubMed ID: 37935612
[TBL] [Abstract][Full Text] [Related]
15. Tumor induced osteomalacia: A single center experience on 17 patients.
Crotti C; Bartoli F; Coletto LA; Manara M; Marini E; Daolio PA; Parafioriti A; Armiraglio E; Zucchi F; Sinigaglia L; Caporali R; Varenna M
Bone; 2021 Nov; 152():116077. PubMed ID: 34175499
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic osteomalacia: two case reports with surprisingly different outcomes.
Seijas R; Ares O; Sierra J; Pérez-Dominguez M
Arch Orthop Trauma Surg; 2009 Apr; 129(4):533-9. PubMed ID: 19125258
[TBL] [Abstract][Full Text] [Related]
17. Nonremission and Recurrent Tumor-Induced Osteomalacia: A Retrospective Study.
Li X; Jiang Y; Huo L; Wu H; Liu Y; Jin J; Yu W; Lv W; Zhou L; Xia Y; Wang O; Li M; Xing X; Chi Y; Jiajue R; Cui L; Meng X; Xia W
J Bone Miner Res; 2020 Mar; 35(3):469-477. PubMed ID: 31643101
[TBL] [Abstract][Full Text] [Related]
18. Reports of 17 Chinese patients with tumor-induced osteomalacia.
Yu WJ; He JW; Fu WZ; Wang C; Zhang ZL
J Bone Miner Metab; 2017 May; 35(3):298-307. PubMed ID: 27085966
[TBL] [Abstract][Full Text] [Related]
19. Occult phosphaturic mesenchymal tumour of femur cortex causing oncogenic osteomalacia - diagnostic challenges and clinical outcomes.
Dutta D; Pandey RK; Gogoi R; Solanki N; Madan R; Mondal A; Dogra S; Thapa P
Endokrynol Pol; 2018; 69(2):205-210. PubMed ID: 29442350
[TBL] [Abstract][Full Text] [Related]
20. Tumor-induced osteomalacia - a mystery illness beyond aches, pains, and depression.
Ni HJ; Clifton-Bligh R; Brzozowska MM
Endocr Regul; 2021 Sep; 55(3):163-168. PubMed ID: 34523297
[No Abstract] [Full Text] [Related]
[Next] [New Search]